Clinical Trial Update: Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines switching antiplatelet therapy from clopidogrel to ticagrelor in patients with diabetes and poor clopidogrel respons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Rabin Medical Center | Conditions: Diabetes Mellitus, Coronary Disease | Phase 4 | Status: UNKNOWN